Doctors from the Ninth Hospital's aid to Xinjiang still care about that hot land: a 32 year old Xinjiang patient traveled over 6000 kilometers to seek medical treatment, and after returning to Shanghai, the patient | head and neck | Xinjiang

Release time:Apr 14, 2024 20:42 PM

Dr. Zhang, please help me.

In July, a Xinjiang patient came to the expert clinic of Zhang Ling, the chief physician of the Department of Oral and Maxillofacial Head and Neck Oncology at Shanghai Ninth People's Hospital. 32 year old Abudu comes from Bachu County in Kashgar region. Two months ago, he went to the local health center for treatment due to a walnut sized lump in his mouth. After several twists and turns, it was only then that I learned that there were experts from Shanghai assisting Xinjiang at the Kashgar Second Institute. The local doctor's biopsy suggests that Abudu is suffering from adenoid cystic carcinoma of the left maxilla. Due to limitations in local medical conditions, a remote video consultation was immediately conducted, and Zhang Ling, who had just returned to Shanghai three months ago and was in contact with the 10th batch of Xinjiang aid cadres, was contacted. Zhang Ling carefully read the enhanced CT of the patient's head and neck, and found that the left maxillary bone was damaged significantly, suggesting that the patient should be operated as soon as possible.

From Bachu to Shanghai, one needs to take a long-distance bus for 4 hours to reach the urban area of Kashgar, take a 12 hour train from Kashgar to Urumqi, and then fly from Urumqi for 5 hours to reach Shanghai. From west to east, spanning the entire China, covering a distance of over 6000 kilometers, one journey requires day and night. However, Abudu, who was devoted to seeking medical treatment, had no time to worry about the fatigue of the journey. On the second day of arriving in Shanghai, he rushed to Zhang Ling's expert clinic without stopping.

In this examination, it was found that the tumor was about 4 centimeters by 5 centimeters, and nearly half of the palate had been invaded by the tumor. The patient had also developed corresponding areas of pain and numbness. Zhang Ling immediately contacted the ward, coordinated the beds, opened a green admission channel for Abudujia, and consulted with relevant departments to discuss the patient's condition.

Considering the young age of the patient, if the tumor is simply removed without repair and reconstruction, although the surgical time is shortened, it is difficult to remove and wear the prosthesis. The patient may experience facial collapse, malocclusion, and disrupted occlusal relationships after surgery, which seriously affects their normal life and greatly reduces their postoperative quality of life. To this end, Zhang Ling led a team to design a surgical plan in order for patients to reintegrate into society and return to a dignified life after surgery.

After admission, the patient underwent relevant examinations and the surgery was successfully completed within 8 hours. Although it was already late at night, looking at the patient's almost unchanged facial shape and the maximum preserved anatomical function, all the fatigue was swept away. After surgery, Abudu recovered well and was hospitalized for 10 days, fully recovered and discharged. What's even more gratifying is that in the later stage of diagnosis and treatment, patients no longer need to go through such a long journey. Through the remote consultation model established by Shanghai's aid to Xinjiang, they can complete follow-up and follow-up through video in Kashgar. When leaving the hospital, Abudu repeatedly said "Yaxi" and expressed gratitude to Zhang Ling. At that moment, although the language was not compatible, the emotions of the same Chinese bloodline crossed the barrier of words and infected everyone present.

As the 10th batch of Shanghai's targeted aid to Xinjiang cadres, Zhang Ling has received over 2000 patients and led colleagues in the department to carry out more than 1500 head and neck surgeries, including more than 300 third and fourth level surgeries, in the past two years. He has filled multiple gaps in oral, maxillofacial, and head and neck tumor surgeries in southern Xinjiang, not only serving patients in southern Xinjiang, but also attracting many patients from northern Xinjiang and even outside Xinjiang. Through more than 20 months of guidance, three ethnic doctors have been able to independently complete routine head and neck surgery.

It is reported that Shanghai Ninth People's Hospital has been participating in targeted support for Kashgar Second Hospital for 10 years. We have made outstanding efforts to build a medical highland in southern Xinjiang and cultivate local medical talents, driving the construction of disciplines such as oral and maxillofacial surgery, general surgery, ear, nose, throat, head and neck surgery in the local area. At the same time, we have also laid a solid foundation for the construction of a modern hospital management system in Kashgar Second Hospital and the successful promotion to a tertiary Grade A hospital. It has been over three months since returning to Shanghai's busy clinical work, but Zhang Ling still cares about the patients in Kashgar and the hot land. "As a Party member, defending the country and borders, and nurturing the masses in return are responsibilities, and even more so, responsibilities. The spirit of serving the motherland and the people in aiding Xinjiang has always inspired me to constantly strive in my future medical work."

Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer
Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer

Immunotherapy has been proven to achieve significant therapeutic effects in various solid tumors. However, for pancreatic cancer, known as the "king of cancer", immunotherapy has been ineffective. On August 4, Professor Yu Xianjun, Dean of the Cancer Hospital Affiliated to Fudan University, and Shi Si, Associate Professor of Pancreatic Surgery released a research achievement, which first found the key role of cysteine rich protein 1 in shaping the immunosuppressive microenvironment of pancreatic cancer, filled the gap in the research field of immunosuppressive microenvironment of pancreatic cancer, and provided a theoretical basis for precise immunotherapy of pancreatic cancer patients. Ductal adenocarcinoma of the pancreas is the main type of pancreatic cancer, accounting for about 90% of all pancreatic cancer. Due to its high malignancy and poor treatment effectiveness, pancreatic ductal adenocarcinoma has always been one of the most malignant tumors. In recent years, the level of surgical techniques and comprehensive treatment has been achieved

A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare
A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare

A 14-year-old girl has been experiencing symptoms such as protruding pupils, incomplete eye closure, corneal injury, restricted eye movement, and overall fatigue for several years. The physical discomfort and facial abnormalities caused by eye diseases have made her increasingly reticent, and her temperament is vastly different from before. At the Ophthalmology Department of the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, the pupil has been diagnosed with a rare thyroid ophthalmopathy combined with myasthenia gravis, which requires prompt treatment. However, considering the young age of the pupil, conventional hormone and radiation therapy cannot be used. Therefore, Zhou Huifang, Deputy Director of Ophthalmology and thyroid ophthalmology expert, has developed a targeted drug combined with surgical treatment plan for it, and targeted drug treatment will be performed first. Three months ago, I was hospitalized for one week with mydriasis and received intravenous targeted drug treatment. Afterwards, I went home for observation and followed up on time

The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease
The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease

According to the Statistics of Chinese Dry Eye Expert Consensus, the incidence rate of dry eye in China is about 21%~30%, and it is estimated that there are at least 300 million patients nationwide. The Dry Eye Diagnosis and Treatment Studio of Shanghai Eye Disease Prevention and Treatment Center was officially launched today. In the future, the studio will continuously improve the dry eye diagnosis and treatment standards, and form standardized diagnosis and treatment concepts and service models. Suitable technologies will be promoted to the community, allowing residents to enjoy convenient dry eye diagnosis and treatment services at their doorstep. Executive Dean and Party Secretary Gao Wei stated that this is also one of the livelihood service measures recently launched by the hospital around high-quality development and meeting the needs of the people. It is reported that dry eye syndrome is a chronic ocular surface disease caused by multiple factors. The instability of the tear film or imbalance of the ocular surface microenvironment caused by abnormal quality, quantity, and dynamics of tears can be accompanied by ocular surface inflammatory reactions, tissue damage, and nerve abnormalities, resulting in various discomforts in the eyes

The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice
The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice

The International Dental Implant Consensus Report, jointly written by the Ninth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine and renowned universities in the field of dentistry such as Harvard University, University of Zurich, University of Gothenburg, Columbia University, and University of Frankfurt, has recently been jointly published in top journals in the field of dentistry, including Clinical Periodontology and Clinical Dental Implant Research. This consensus has for the first time established an internationally unified core set of indicators for evaluating the clinical effectiveness of dental implants, covering the five key areas of the field of dental implants. It is of milestone significance for carrying out standardized clinical diagnosis, treatment, and research on dental implants. The core evaluation indicators determined by this consensus will become an important benchmark for scholars in the field of dental implants worldwide to conduct high-quality research. The consensus is composed of 8 top international experts in the field of oral implantation

Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases
Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases

Recently, Catherine, a British girl born in the 1990s, received autologous peripheral blood hematopoietic stem cell transfusion at the Cancer Center of Shanghai Jiahui International Hospital, and was successfully discharged from the warehouse. She is now on her way back to China after being discharged from the hospital. She is also the first patient at Shanghai Jiahui International Hospital to complete relevant treatments. In 2019, Catherine was diagnosed with Hodgkin's lymphoma in the UK, and after treatment, the disease completely improved. During her work and life in China in 2021, she went to seek medical attention due to multiple enlarged lymph nodes. Pathological biopsy confirmed a recurrence of Hodgkin's lymphoma, and through combined targeted drug treatment, her condition was temporarily under control. Last year in the second half of the year, when the disease recurred, the girl began to use immunotherapy combined with targeted drugs for treatment. Expert evaluation suggests that for young patients with hematological tumors, the risk of recurrence is high and treatment difficulty is increasing in the future. Autologous hematopoietic stem cell therapy is recommended